Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 040311

Expand all

MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)
2.5MG
Marketing Status: Discontinued

Active Ingredient: MEDROXYPROGESTERONE ACETATE
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040311
Product Number: 001
Approval Date: Dec 1, 1999
Applicant Holder Full Name: DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)
5MG
Marketing Status: Discontinued

Active Ingredient: MEDROXYPROGESTERONE ACETATE
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040311
Product Number: 002
Approval Date: Dec 1, 1999
Applicant Holder Full Name: DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)
10MG
Marketing Status: Discontinued

Active Ingredient: MEDROXYPROGESTERONE ACETATE
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A040311
Product Number: 003
Approval Date: Dec 1, 1999
Applicant Holder Full Name: DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information